Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1997

Primary Completion Date

April 30, 2003

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

dexamethasone

DRUG

doxorubicin hydrochloride

DRUG

valspodar

DRUG

vincristine sulfate

Trial Locations (40)

10021

Memorial Sloan-Kettering Cancer Center, New York

New York Presbyterian Hospital - Cornell Campus, New York

10029

Mount Sinai Medical Center, NY, New York

11030

CCOP - North Shore University Hospital, Manhasset

Schneider Children's Hospital at North Shore, Manhasset

13210

State University of New York - Upstate Medical University, Syracuse

13217

CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C., Syracuse

19899

CCOP - Christiana Care Health Services, Wilmington

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

27710

Duke Comprehensive Cancer Center, Durham

33140

CCOP - Mount Sinai Medical Center, Miami Beach

38103

University of Tennessee, Memphis Cancer Center, Memphis

55455

University of Minnesota Cancer Center, Minneapolis

63110

Barnes-Jewish Hospital, St Louis

65203

Ellis Fischel Cancer Center - Columbia, Columbia

89106

CCOP - Southern Nevada Cancer Research Foundation, Las Vegas

92093-0658

University of California San Diego Cancer Center, La Jolla

94143-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

20307-5000

Walter Reed Army Medical Center, Washington D.C.

60637-1470

University of Chicago Cancer Research Center, Chicago

52242-1009

Holden Comprehensive Cancer Center at The University of Iowa, Iowa City

02115

Dana-Farber Cancer Institute, Boston

01655

University of Massachusetts Memorial Medical Center, Worcester

68198-3330

University of Nebraska Medical Center, Omaha

03756-0002

Norris Cotton Cancer Center, Lebanon

14263-0001

Roswell Park Cancer Institute, Buffalo

27599-7295

Lineberger Comprehensive Cancer Center, UNC, Chapel Hill

27104-4241

CCOP - Southeast Cancer Control Consortium, Winston-Salem

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

02903

Rhode Island Hospital, Providence

05401-3498

Vermont Cancer Center, Burlington

23298-0037

MBCCOP - Massey Cancer Center, Richmond

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6ZB

Moncton Hospital, Moncton

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

L2R 5K3

Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines

M5G 2C4

Toronto General Hospital, Toronto

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

H2L-4M1

Centre Hospitalier de l'Universite de Montreal, Montreal

H2W 1S6

McGill University, Montreal

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

SWOG Cancer Research Network

NETWORK

collaborator

Cancer and Leukemia Group B

NETWORK

collaborator

NCIC Clinical Trials Group

NETWORK

collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002878 - Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter